Stockreport

Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout [Yahoo! Finance]

Karuna Therapeutics, Inc.  (KRTX) 
PDF In the year-ago quarter, the company posted a loss of $2.22 per share. The loss increased from the year-ago quarter due to higher operating expenses. In the fourth qu [Read more]